Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Laura Elizabeth Hughes

TitleInstructor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Hughes LE, Adams NE, Rouse MA, Naessens M, Shaw A, Murley AG, Cope TE, Holland N, Nesbitt D, Street D, Whiteside DJ, Rowe JB. GABAergic modulation of beta power enhances motor adaptation in frontotemporal lobar degeneration. Alzheimers Dement. 2025 May; 21(5):e14531. PMID: 39968697.
      View in: PubMed
    2. Perry A, Hughes LE, Adams NE, Naessens M, Kloosterman NA, Rouse MA, Murley AG, Street D, Jones PS, Rowe JB. Frontotemporal lobar degeneration changes neuronal beta-frequency dynamics during the mismatch negativity response. Neuroimage Clin. 2024; 44:103671. PMID: 39305652.
      View in: PubMed
    3. Williams RS, Adams NE, Hughes LE, Rouse MA, Murley AG, Naessens M, Street D, Holland N, Rowe JB. Syndromes associated with frontotemporal lobar degeneration change response patterns on visual analogue scales. Sci Rep. 2023 06 02; 13(1):8939. PMID: 37268659.
      View in: PubMed
    4. Adams NE, Jafarian A, Perry A, Rouse MA, Shaw AD, Murley AG, Cope TE, Bevan-Jones WR, Passamonti L, Street D, Holland N, Nesbitt D, Hughes LE, Friston KJ, Rowe JB. Neurophysiological consequences of synapse loss in progressive supranuclear palsy. Brain. 2023 06 01; 146(6):2584-2594. PMID: 36514918.
      View in: PubMed
    5. Jafarian A, Hughes LE, Adams NE, Lanskey JH, Naessens M, Rouse MA, Murley AG, Friston KJ, Rowe JB. Neurochemistry-enriched dynamic causal models of magnetoencephalography, using magnetic resonance spectroscopy. Neuroimage. 2023 08 01; 276:120193. PMID: 37244323.
      View in: PubMed
    6. Perry A, Hughes LE, Adams N, Naessens M, Murley AG, Rouse MA, Street D, Jones PS, Cope TE, Kocagoncu E, Rowe JB. The neurophysiological effect of NMDA-R antagonism of frontotemporal lobar degeneration is conditional on individual GABA concentration. Transl Psychiatry. 2022 08 27; 12(1):348. PMID: 36030249.
      View in: PubMed
    7. Vaghari D, Bruna R, Hughes LE, Nesbitt D, Tibon R, Rowe JB, Maestu F, Henson RN. A multi-site, multi-participant magnetoencephalography resting-state dataset to study dementia: The BioFIND dataset. Neuroimage. 2022 09; 258:119344. PMID: 35660461.
      View in: PubMed
    8. Cope TE, Hughes LE, Phillips HN, Adams NE, Jafarian A, Nesbitt D, Assem M, Woolgar A, Duncan J, Rowe JB. Causal Evidence for the Multiple Demand Network in Change Detection: Auditory Mismatch Magnetoencephalography across Focal Neurodegenerative Diseases. J Neurosci. 2022 04 13; 42(15):3197-3215. PMID: 35260433.
      View in: PubMed
    9. Kocagoncu E, Nesbitt D, Emery T, Hughes LE, Henson RN, Rowe JB. Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease. J Neurosci. 2022 02 16; 42(7):1362-1373. PMID: 35012965.
      View in: PubMed
    10. Kocagoncu E, Klimovich-Gray A, Hughes LE, Rowe JB. Evidence and implications of abnormal predictive coding in dementia. Brain. 2021 12 16; 144(11):3311-3321. PMID: 34240109.
      View in: PubMed
    11. Adams NE, Hughes LE, Rouse MA, Phillips HN, Shaw AD, Murley AG, Cope TE, Bevan-Jones WR, Passamonti L, Street D, Holland N, Nesbitt D, Friston K, Rowe JB. GABAergic cortical network physiology in frontotemporal lobar degeneration. Brain. 2021 08 17; 144(7):2135-2145. PMID: 33710299.
      View in: PubMed
    12. Shaw AD, Hughes LE, Moran R, Coyle-Gilchrist I, Rittman T, Rowe JB. In Vivo Assay of Cortical Microcircuitry in Frontotemporal Dementia: A Platform for Experimental Medicine Studies. Cereb Cortex. 2021 02 05; 31(3):1837-1847. PMID: 31216360.
      View in: PubMed
    13. Correia MM, Rittman T, Barnes CL, Coyle-Gilchrist IT, Ghosh B, Hughes LE, Rowe JB. Towards accurate and unbiased imaging-based differentiation of Parkinson's disease, progressive supranuclear palsy and corticobasal syndrome. Brain Commun. 2020; 2(1):fcaa051. PMID: 32671340.
      View in: PubMed
    14. Adams NE, Hughes LE, Phillips HN, Shaw AD, Murley AG, Nesbitt D, Cope TE, Bevan-Jones WR, Passamonti L, Rowe JB. GABA-ergic Dynamics in Human Frontotemporal Networks Confirmed by Pharmaco-Magnetoencephalography. J Neurosci. 2020 02 19; 40(8):1640-1649. PMID: 31915255.
      View in: PubMed
    15. Borchert RJ, Rittman T, Rae CL, Passamonti L, Jones SP, Vatansever D, Vázquez Rodríguez P, Ye Z, Nombela C, Hughes LE, Robbins TW, Rowe JB. Atomoxetine and citalopram alter brain network organization in Parkinson's disease. Brain Commun. 2019; 1(1):fcz013. PMID: 31886460.
      View in: PubMed
    16. Hughes LE, Henson RN, Pereda E, Bruña R, López-Sanz D, Quinn AJ, Woolrich MW, Nobre AC, Rowe JB, Maestú F. Biomagnetic biomarkers for dementia: A pilot multicentre study with a recommended methodological framework for magnetoencephalography. Alzheimers Dement (Amst). 2019 Dec; 11:450-462. PMID: 31431918.
      View in: PubMed
    17. Hughes LE, Rittman T, Robbins TW, Rowe JB. Reply: Brain oscillations, inhibition and social inappropriateness in frontotemporal degeneration. Brain. 2018 10 01; 141(10):e74. PMID: 30212860.
      View in: PubMed
    18. Sami S, Williams N, Hughes LE, Cope TE, Rittman T, Coyle-Gilchrist ITS, Henson RN, Rowe JB. Neurophysiological signatures of Alzheimer's disease and frontotemporal lobar degeneration: pathology versus phenotype. Brain. 2018 08 01; 141(8):2500-2510. PMID: 30060017.
      View in: PubMed
    19. Hughes LE, Rittman T, Robbins TW, Rowe JB. Reorganization of cortical oscillatory dynamics underlying disinhibition in frontotemporal dementia. Brain. 2018 08 01; 141(8):2486-2499. PMID: 29992242.
      View in: PubMed
    20. Borchert RJ, Rittman T, Passamonti L, Ye Z, Sami S, Jones SP, Nombela C, Rodríguez PV, Vatansever D, Rae CL, Hughes LE, Robbins TW, Rowe JB. Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's Disease. Neuropsychopharmacology. 2016 07; 41(8):2188. PMID: 27282105.
      View in: PubMed
    21. Rae CL, Nombela C, Rodríguez PV, Ye Z, Hughes LE, Jones PS, Ham T, Rittman T, Coyle-Gilchrist I, Regenthal R, Sahakian BJ, Barker RA, Robbins TW, Rowe JB. Atomoxetine restores the response inhibition network in Parkinson's disease. Brain. 2016 08; 139(Pt 8):2235-48. PMID: 27343257.
      View in: PubMed
    22. Phillips HN, Blenkmann A, Hughes LE, Kochen S, Bekinschtein TA, Rowe JB. Convergent evidence for hierarchical prediction networks from human electrocorticography and magnetoencephalography. Cortex. 2016 09; 82:192-205. PMID: 27389803.
      View in: PubMed
    23. Borchert RJ, Rittman T, Passamonti L, Ye Z, Sami S, Jones SP, Nombela C, Vázquez Rodríguez P, Vatansever D, Rae CL, Hughes LE, Robbins TW, Rowe JB. Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's Disease. Neuropsychopharmacology. 2016 07; 41(8):2171-7. PMID: 26837463.
      View in: PubMed
    24. Zhang J, Rittman T, Nombela C, Fois A, Coyle-Gilchrist I, Barker RA, Hughes LE, Rowe JB. Different decision deficits impair response inhibition in progressive supranuclear palsy and Parkinson's disease. Brain. 2016 Jan; 139(Pt 1):161-73. PMID: 26582559.
      View in: PubMed
    25. Phillips HN, Blenkmann A, Hughes LE, Bekinschtein TA, Rowe JB. Hierarchical Organization of Frontotemporal Networks for the Prediction of Stimuli across Multiple Dimensions. J Neurosci. 2015 Jun 24; 35(25):9255-64. PMID: 26109651.
      View in: PubMed
    26. Hughes LE, Rittman T, Regenthal R, Robbins TW, Rowe JB. Improving response inhibition systems in frontotemporal dementia with citalopram. Brain. 2015 Jul; 138(Pt 7):1961-75. PMID: 26001387.
      View in: PubMed
    27. Rae CL, Hughes LE, Anderson MC, Rowe JB. The prefrontal cortex achieves inhibitory control by facilitating subcortical motor pathway connectivity. J Neurosci. 2015 Jan 14; 35(2):786-94. PMID: 25589771.
      View in: PubMed
    28. Hughes LE, Rowe JB, Ghosh BC, Carlyon RP, Plack CJ, Gockel HE. The binaural masking level difference: cortical correlates persist despite severe brain stem atrophy in progressive supranuclear palsy. J Neurophysiol. 2014 Dec 15; 112(12):3086-94. PMID: 25231610.
      View in: PubMed
    29. Rae CL, Hughes LE, Weaver C, Anderson MC, Rowe JB. Selection and stopping in voluntary action: a meta-analysis and combined fMRI study. Neuroimage. 2014 Feb 01; 86:381-91. PMID: 24128740.
      View in: PubMed
    30. Nombela C, Hughes LE, Owen AM, Grahn JA. Into the groove: can rhythm influence Parkinson's disease? Neurosci Biobehav Rev. 2013 Dec; 37(10 Pt 2):2564-70. PMID: 24012774.
      View in: PubMed
    31. Hughes LE, Rowe JB. The impact of neurodegeneration on network connectivity: a study of change detection in frontotemporal dementia. J Cogn Neurosci. 2013 May; 25(5):802-13. PMID: 23469882.
      View in: PubMed
    32. Hughes LE, Ghosh BC, Rowe JB. Reorganisation of brain networks in frontotemporal dementia and progressive supranuclear palsy. Neuroimage Clin. 2013; 2:459-468. PMID: 23853762.
      View in: PubMed
    33. Zhang J, Hughes LE, Rowe JB. Selection and inhibition mechanisms for human voluntary action decisions. Neuroimage. 2012 Oct 15; 63(1):392-402. PMID: 22776456.
      View in: PubMed
    34. Rae CL, Correia MM, Altena E, Hughes LE, Barker RA, Rowe JB. White matter pathology in Parkinson's disease: the effect of imaging protocol differences and relevance to executive function. Neuroimage. 2012 Sep; 62(3):1675-84. PMID: 22713671.
      View in: PubMed
    35. Hughes LE, Altena E, Barker RA, Rowe JB. Perseveration and choice in Parkinson's disease: the impact of progressive frontostriatal dysfunction on action decisions. Cereb Cortex. 2013 Jul; 23(7):1572-81. PMID: 22661404.
      View in: PubMed
    36. Hughes LE, Nestor PJ, Hodges JR, Rowe JB. Magnetoencephalography of frontotemporal dementia: spatiotemporally localized changes during semantic decisions. Brain. 2011 Sep; 134(Pt 9):2513-22. PMID: 21840892.
      View in: PubMed
    37. Hughes LE, Barker RA, Owen AM, Rowe JB. Parkinson's disease and healthy aging: independent and interacting effects on action selection. Hum Brain Mapp. 2010 Dec; 31(12):1886-99. PMID: 20162604.
      View in: PubMed
    38. Hughes LE, Bates TC, Aimola Davies AM. Dissociations in rod bisection: the effect of viewing conditions on perception and action. Cortex. 2008 Oct; 44(9):1279-87. PMID: 18761142.
      View in: PubMed
    39. Hughes LE, Babski-Reeves K, Smith-Jackson T. Effects of psychosocial and individual factors on physiological risk factors for upper extremity musculoskeletal disorders while typing. Ergonomics. 2007 Feb; 50(2):261-74. PMID: 17419158.
      View in: PubMed
    40. Hughes LE, Bates TC, Aimola Davies AM. The effects of local and global processing demands on perception and action. Brain Cogn. 2005 Oct; 59(1):71-81. PMID: 16019116.
      View in: PubMed
    41. Hughes LE, Bates TC, Aimola Davies A. Grasping at sticks: pseudoneglect for perception but not action. Exp Brain Res. 2004 Aug; 157(3):397-402. PMID: 15221169.
      View in: PubMed
    42. Hughes LE, Wilkins AJ. Reading at a distance: implications for the design of text in children's big books. Br J Educ Psychol. 2002 Jun; 72(Pt 2):213-26. PMID: 12028609.
      View in: PubMed
    Hughes's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (142) concept(s)
    _
    Co-Authors Expand Description
    See all (1) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)